Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
February 02, 2023 at 13:49 PM EST
The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
